Rice Hall James & Associates’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,453
| Closed | -$426K | – | 254 |
|
|
2025
Q1 | $426K | Sell |
46,453
-28,026
| -38% | -$176K | 0.03% | 228 |
|
|
2024
Q4 | $498K | Sell |
74,479
-1,563
| -2% | -$13.8K | 0.03% | 228 |
|
|
2024
Q3 | $764K | Buy |
76,042
+10,163
| +15% | +$148K | 0.04% | 212 |
|
|
2024
Q2 | $1.03M | Sell |
65,879
-339
| -0.5% | -$5.68K | 0.06% | 208 |
|
|
2024
Q1 | $1.45M | Sell |
66,218
-774
| -1% | -$17.2K | 0.08% | 191 |
|
|
2023
Q4 | $1.3M | Sell |
66,992
-3,013
| -4% | -$55K | 0.08% | 205 |
|
|
2023
Q3 | $1.29M | Buy |
70,005
+5,557
| +9% | +$100K | 0.08% | 198 |
|
|
2023
Q2 | $1.19M | Buy |
64,448
+12,984
| +25% | +$307K | 0.07% | 207 |
|
|
2023
Q1 | $1.49M | Sell |
51,464
-2,503
| -5% | -$66.6K | 0.08% | 217 |
|
|
2022
Q4 | $1.5M | Sell |
53,967
-753
| -1% | -$28.6K | 0.09% | 215 |
|
|
2022
Q3 | $3M | Sell |
54,720
-4,452
| -8% | -$244K | 0.17% | 138 |
|
|
2022
Q2 | $3.25M | Buy |
59,172
+394
| +0.7% | +$14.5K | 0.16% | 132 |
|
|
2022
Q1 | $2.18M | Buy |
58,778
+2,367
| +4% | +$84.5K | 0.09% | 203 |
|
|
2021
Q4 | $1.37M | Sell |
56,411
-5,729
| -9% | -$192K | 0.05% | 230 |
|
|
2021
Q3 | $2.8M | Buy |
62,140
+388
| +0.6% | +$16.3K | 0.1% | 154 |
|
|
2021
Q2 | $2.88M | Sell |
61,752
-9,032
| -13% | -$461K | 0.1% | 156 |
|
|
2021
Q1 | $3.92M | Buy |
70,784
+1,583
| +2% | +$96.3K | 0.13% | 128 |
|
|
2020
Q4 | $4.3M | Sell |
69,201
-731
| -1% | -$44.8K | 0.15% | 112 |
|
|
2020
Q3 | $4.09M | Buy |
69,932
+7,987
| +13% | +$592K | 0.16% | 109 |
|
|
2020
Q2 | $6.91M | Sell |
61,945
-9,667
| -13% | -$688K | 0.3% | 93 |
|
|
2020
Q1 | $4.82M | Sell |
71,612
-13,734
| -16% | -$1.38M | 0.27% | 103 |
|
|
2019
Q4 | $11.8M | Sell |
85,346
-6,713
| -7% | -$871K | 0.4% | 96 |
|
|
2019
Q3 | $9.67M | Sell |
92,059
-505
| -0.5% | -$50.4K | 0.35% | 101 |
|
|
2019
Q2 | $9.83M | Sell |
92,564
-1,748
| -2% | -$230K | 0.33% | 104 |
|
|
2019
Q1 | $14.6M | Buy |
94,312
+23,321
| +33% | +$2.7M | 0.47% | 80 |
|
|
2018
Q4 | $6.6M | Buy |
70,991
+35,129
| +98% | +$5.02M | 0.24% | 113 |
|
|
2018
Q3 | $6.69M | Buy |
35,862
+14,305
| +66% | +$4.08M | 0.24% | 108 |
|
|
2018
Q2 | $9.05M | Buy |
+21,557
| New | +$7.27M | 0.33% | 102 |
|
Rice Hall James & Associates's OPTN Position: Q2 2025 in Review
Rice Hall James & Associates sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 46,453 shares — an estimated $426K sold.
Rice Hall James & Associates first reported a position in OPTN in Q2 2018 and held it in 28 quarters. The position peaked at $14.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Rice Hall James & Associates reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Rice Hall James & Associates sold 46,453 OptiNose shares in Q2 2025, an estimated $426K.
- Rice Hall James & Associates first reported a position in OptiNose in Q2 2018 and held it in 28 quarters.
- Rice Hall James & Associates's OptiNose position peaked at $14.6M in Q1 2019.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Rice Hall James & Associates's 13F filing for Q2 2025, filed 11 Aug 2025.